Clearside Biomedical(CLSD) - 2021 Q4 - Annual Report
Clearside Biomedical(CLSD)2022-03-10 16:00UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to __________ | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------- ...